Pattern of care of prostate cancer patients across the Martinique: results of a population-based study in the Caribbean

[1]  Melissa Matz,et al.  Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries , 2018, The Lancet.

[2]  E. Schaeffer,et al.  Re: Active surveillance for prostate cancer compared with immediate treatment: an economic analysis. , 2013, The Journal of urology.

[3]  M. Aapro,et al.  Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology. , 2017, European urology.

[4]  H. D. de Koning,et al.  Is prostate cancer different in black men? Answers from 3 natural history models , 2017, Cancer.

[5]  P. Blanchet,et al.  Active Surveillance for Favorable Risk Prostate Cancer in African Caribbean Men: Results of a Prospective Study , 2017, The Journal of urology.

[6]  E. Schaeffer,et al.  Is active surveillance a suitable option for African American men with prostate cancer? A systemic literature review , 2017, Prostate Cancer and Prostatic Diseases.

[7]  V. Vinh-Hung,et al.  Curative brachytherapy for prostate cancer in African-Caribbean patients: A retrospective analysis of 370 consecutive cases. , 2017, Brachytherapy.

[8]  D. Forman,et al.  Prostate cancer burden in Central and South America. , 2016, Cancer epidemiology.

[9]  S. Persaud,et al.  A Clinicopathological Profile of Prostate Cancer in Trinidad and Tobago , 2016, Advances in urology.

[10]  M. Schwaiger,et al.  Diagnostic Efficacy of (68)Gallium-PSMA Positron Emission Tomography Compared to Conventional Imaging for Lymph Node Staging of 130 Consecutive Patients with Intermediate to High Risk Prostate Cancer. , 2016, The Journal of urology.

[11]  F. Bray,et al.  Cancer patterns, trends and projections in Latin America and the Caribbean: a global context. , 2016, Salud publica de Mexico.

[12]  V. Vinh-Hung,et al.  Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: A study of 274 African-Caribbean patients. , 2015, Brachytherapy.

[13]  B. Delahunt,et al.  The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma: Definition of Grading Patterns and Proposal for a New Grading System , 2015, The American journal of surgical pathology.

[14]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[15]  A. Jemal,et al.  Global cancer statistics, 2012 , 2015, CA: a cancer journal for clinicians.

[16]  Michael M. Maddox,et al.  Active surveillance of prostate cancer in African American men. , 2014, Urology.

[17]  M. Romana,et al.  Copy Number Variation of GSTT1 and GSTM1 and the Risk of Prostate Cancer in a Caribbean Population of African Descent , 2014, PloS one.

[18]  G. Cancel-Tassin,et al.  Region 2 of 8q24 is associated with the risk of aggressive prostate cancer in Caribbean men of African descent from Guadeloupe (French West Indies) , 2014, Asian journal of andrology.

[19]  T. Sugihara,et al.  Management of prostate cancer in older patients: updated recommendations of a working group of the International Society of Geriatric Oncology. , 2014, The Lancet. Oncology.

[20]  P. Blanchet,et al.  Intérêt de la densité du PSA comme facteur prédictif chez les patients afro-caribéens éligibles à la surveillance active du cancer de prostate selon les critères du protocole français , 2014 .

[21]  A. Sasco,et al.  Geographic variations and temporal trends in prostate cancer in Martinique over a 25-year period , 2014, BMC Research Notes.

[22]  B. Tressières,et al.  Cancer de prostate non localisé au diagnostic en Guadeloupe , 2014 .

[23]  N. Waugh,et al.  Thirty-year trends in incidence and age-distribution of prostate cancer in Kingston and St Andrew, Jamaica, 1978-2007. , 2014, The West Indian medical journal.

[24]  K. Ylitalo,et al.  Active surveillance for low-risk prostate cancer in African American men: a multi-institutional experience. , 2014, Urology.

[25]  F. Rozet,et al.  Recommandations en onco-urologie 2013 du CCAFU : Cancer de la prostate , 2013 .

[26]  Richard Sullivan,et al.  Planning cancer control in Latin America and the Caribbean. , 2013, The Lancet. Oncology.

[27]  C. Mathers,et al.  Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions , 2012, The Lancet.

[28]  P. Blanchet,et al.  Radiohormonothérapie dans le cancer de la prostate à haut risque : quels résultats sur une population Antillaise ? , 2012 .

[29]  C. Pettaway,et al.  Prostate cancer incidence and mortality among Puerto Ricans: an updated analysis comparing men in Puerto Rico with US racial/ethnic groups. , 2012, Puerto Rico health sciences journal.

[30]  A. Jemal,et al.  International variation in prostate cancer incidence and mortality rates. , 2012, European urology.

[31]  P. Albertsen.  When is active surveillance the appropriate treatment for prostate cancer? , 2011, Acta oncologica.

[32]  M. Kattan,et al.  Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology , 2010, BJU international.

[33]  X. Rébillard,et al.  Le cancer de la prostate en France en 2001 : état des pratiques et facteurs associés à la réalisation d’une prostatectomie totale , 2009 .

[34]  P. Layne,et al.  Ethnicity and cancer in Guyana, South America , 2009, Infectious Agents and Cancer.

[35]  M. Freedman,et al.  Prostate cancer disparities in Black men of African descent: a comparative literature review of prostate cancer burden among Black men in the United States, Caribbean, United Kingdom, and West Africa , 2009, Infectious Agents and Cancer.

[36]  G. Verhoest,et al.  [Prostate cancer in Guadeloupe (French West Indies): incidence, mortality and clinicopathological features]. , 2009, Bulletin du cancer.

[37]  G. Verhoest,et al.  Cancer de la prostate en Guadeloupe : incidence, mortalité, caractéristiques cliniques et anatomopathologiques , 2009 .

[38]  H. Azaloux,et al.  Cancer incidence in Martinique: a model of epidemiological transition , 2007, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[39]  A. Neugut,et al.  Cancer Incidence and Mortality in the Caribbean , 2007, Cancer investigation.

[40]  D. Parkin,et al.  The evolution of the population-based cancer registry , 2006, Nature Reviews Cancer.

[41]  J. Kouyoumdjian,et al.  [Case-control study of the genes of receptors of the androgens of vitamin-D and of 5-alphareductase in a population of Afro-Caribbean population with prostate cancer]. , 2006, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[42]  P. Blanchet,et al.  Prostate cancer incidence in guadeloupe, a French Caribbean archipelago. , 2005, European urology.

[43]  Hans Garmo,et al.  Radical prostatectomy versus watchful waiting in early prostate cancer. , 2005, The New England journal of medicine.

[44]  L. Garrote,et al.  Incidence, mortality and survival from prostate cancer in Cuba, 1977–1999 , 2004, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[45]  E. Crawford,et al.  Epidemiology of prostate cancer. , 2003, Urology.

[46]  M Bolla,et al.  EAU guidelines on prostate cancer. , 2001, European urology.

[47]  P. Walsh,et al.  The epidemiology of prostate cancer in Jamaica. , 1998, Journal of Urology.

[48]  B. Armstrong.  The role of the cancer registry in cancer control , 1992, Cancer Causes & Control.

[49]  D. Parkin,et al.  Ethnicity and cancer risk in São Paulo, Brazil. , 1991, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[50]  A. Ouzzane,et al.  [CCAFU french national guidelines 2016-2018 on prostate cancer]. , 2016, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[51]  T. H. van der Kwast,et al.  EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. , 2014, European urology.

[52]  P. Nevoux,et al.  [Stage IV prostate cancer in Guadeloupe, a French Caribbean archipelago]. , 2014, Progrès en urologie (Paris).

[53]  P. Nevoux,et al.  [The significance of PSA density as predictive factor in Afro-Caribbean patients eligible for active surveillance by the French protocol criteria]. , 2014, Progrès en urologie (Paris).

[54]  P. Blanchet,et al.  [Radiotherapy with androgen deprivation in high-risk prostate cancer: what outcomes on a Caribbean population?]. , 2012, Progrès en urologie (Paris).

[55]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[56]  A. Guizard,et al.  [Prostate cancer management and factors associated with radical prostatectomy in France in 2001]. , 2009, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[57]  A. Villers,et al.  A population-based study on management of prostate cancer in four regions of France , 2001, Prostate Cancer and Prostatic Diseases.

[58]  A. Villers,et al.  A population-based study on radical prostatectomy in France , 2001, Prostate Cancer and Prostatic Diseases.

[59]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.